Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2858
Verastem, Inc.
6.3
3
USD
+3.09%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.09%
Monthly Change
+12.83%
6 month change
-33.72%
Year Change
+33.54%
Previous Close
6.1
4
Open
6.3
3
Bid
Ask
Low
6.3
3
High
6.3
3
Volume
67
Markets
US Stock Market
Healthcare
VSTM
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Total assets
101.54 M
131.7 M
196.26 M
176.85 M
246.44 M
Total liabilities
130.43 M
164.13 M
160.21 M
192.38 M
189.25 M
Total equity
-28.89 M
-32.43 M
36.06 M
-15.53 M
57.2 M
Total liabilities & shareholders' equities
101.54 M
131.7 M
196.26 M
176.85 M
246.44 M
Total debt
40.72 M
72.22 M
74.74 M
78.31 M
76.33 M
Net debt
-48.08 M
-45.38 M
-89.56 M
-59.39 M
-128.67 M
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
News
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)
Verastem stock initiated at Buy by BTIG with $19 price target
Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?
Jefferies reiterates Verastem stock rating on launch progress
Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript
Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results